儿童急性白血病化疗后合并慢性播散性念珠菌病的临床特征及预后:一项多中心研究

江信宏, 刘佩君, 吴椿萍, 翁开枝, 庄树铨, 黄淑贤, 王晓芳, 郑湧智

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (5) : 540-547.

PDF(920 KB)
HTML
PDF(920 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (5) : 540-547. DOI: 10.7499/j.issn.1008-8830.2409002
论著·临床研究

儿童急性白血病化疗后合并慢性播散性念珠菌病的临床特征及预后:一项多中心研究

作者信息 +

Clinical characteristics and prognosis of chronic disseminated candidiasis in children with acute leukemia following chemotherapy: a multicenter clinical study

Author information +
文章历史 +

摘要

目的 探讨儿童急性白血病(acute leukemia, AL)化疗后合并慢性播散性念珠菌病(chronic disseminated candidiasis, CDC)的临床特征及预后。 方法 采用回顾性分析方法,以2015年1月—2023年12月在福建医科大学附属协和医院、福建医科大学附属漳州市医院及福建医科大学附属泉州第一医院的AL化疗后合并CDC(包括确诊、临床诊断与拟诊)的患儿作为研究对象,对其临床特征及预后进行分析。 结果 所有AL患儿化疗后合并CDC的发生率为1.92%(32/1 668);急性淋巴细胞白血病患儿中,高危组CDC的发生率显著高于低危组(P=0.002)。所有患儿均表现为粒细胞缺乏期间抗生素治疗无效的发热,81%(26/32)累及肝脏。97%(31/32)的患儿C反应蛋白(C-reactive protein, CRP)明显升高(≥50 mg/L)。两性霉素B脂质体联合卡泊芬净或泊沙康唑治疗CDC的有效率为66%(19/29),高于卡泊芬净(9%,2/22)或两性霉素B脂质体(18%,2/11)单药治疗。总体治愈率为72%(23/32)。治疗失败组CRP≥50 mg/L和/或β-D-葡聚糖试验阳性持续时间超过2周、卡泊芬净治疗期间出现突破性感染的比例显著高于治疗成功组(均P<0.05)。 结论 儿童AL化疗后合并CDC可能与高强度化疗所致的持续粒细胞缺乏相关;以两性霉素B脂质体为基础的联合抗真菌方案有较高的治愈率,持续高CRP及β-D-葡聚糖试验阳性可能预后不良。

Abstract

Objective To investigate the clinical characteristics and prognosis of chronic disseminated candidiasis (CDC) in children with acute leukemia (AL) following chemotherapy. Methods A retrospective analysis was conducted on children diagnosed with CDC (including confirmed, clinically diagnosed, and suspected cases) after AL chemotherapy from January 2015 to December 2023 at Fujian Medical University Union Hospital, Zhangzhou Municipal Hospital, and Quanzhou First Hospital Affiliated to Fujian Medical University. Clinical characteristics and prognosis were analyzed. Results The incidence of CDC in children with AL following chemotherapy was 1.92% (32/1 668). Among the children with acute lymphoblastic leukemia, the incidence of CDC in the high-risk group was significantly higher than in the low-risk group (P=0.002). All patients presented with fever unresponsive to antibiotics during the neutropenic period, with 81% (26/32) involving the liver. C-reactive protein (CRP) levels were significantly elevated (≥50 mg/L) in 97% (31/32) of the patients. The efficacy of combined therapy with liposomal amphotericin B and caspofungin or posaconazole for CDC was 66% (19/29), higher than with caspofungin (9%, 2/22) or liposomal amphotericin B (18%, 2/11) monotherapy. The overall cure rate was 72% (23/32). The proportion of patients with CRP ≥50 mg/L and/or a positive β-D-glucan test for more than 2 weeks and breakthrough infections during caspofungin treatment was significantly higher in the treatment failure group compared to the successful treatment group (P<0.05). Conclusions CDC in children with AL after chemotherapy may be associated with prolonged neutropenia due to intensive chemotherapy. Combination antifungal regimens based on liposomal amphotericin B have a higher cure rate, while persistently high CRP levels and positive β-D-glucan tests may indicate poor prognosis.

关键词

侵袭性真菌病 / 慢性播散性念珠菌病 / 急性白血病 / 抗真菌治疗 / 预后 / 儿童

Key words

Invasive fungal disease / Chronic disseminated candidiasis / Acute leukemia / Antifungal therapy / Prognosis / Child

引用本文

导出引用
江信宏, 刘佩君, 吴椿萍, . 儿童急性白血病化疗后合并慢性播散性念珠菌病的临床特征及预后:一项多中心研究[J]. 中国当代儿科杂志. 2025, 27(5): 540-547 https://doi.org/10.7499/j.issn.1008-8830.2409002
Xin-Hong JIANG, Pei-Jun LIU, Chun-Ping WU, et al. Clinical characteristics and prognosis of chronic disseminated candidiasis in children with acute leukemia following chemotherapy: a multicenter clinical study[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(5): 540-547 https://doi.org/10.7499/j.issn.1008-8830.2409002

参考文献

1
Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia[J]. Haematologica, 2020, 105(11): 2524-2539. PMCID: PMC7604619. DOI: 10.3324/haematol.2020.247031 .
2
Rubnitz JE, Kaspers GJL. How I treat pediatric acute myeloid leukemia[J]. Blood, 2021, 138(12): 1009-1018. DOI: 10.1182/blood.2021011694 .
3
Li MJ, Chang HH, Yang YL, et al. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan pediatric oncology group protocol: a 16-year tertiary single-institution experience[J]. Pediatr Blood Cancer, 2017, 64(10): e26535. DOI: 10.1002/pbc.26535 .
4
中华医学会儿科学分会血液学组, 《中华儿科杂志》编辑委员会. 儿童血液系统疾病及恶性肿瘤侵袭性真菌病诊疗建议[J]. 中华儿科杂志, 2014, 52(6): 426-429. DOI: 10.3760/cma.j.issn.0578-1310.2014.06.006 .
5
李琰冰, 徐英春, 张丽. 不容忽视的儿童侵袭性真菌感染[J]. 中华实用儿科临床杂志, 2024, 39(1): 2-6. DOI: 10.3760/cma.j.cn101070-20230621-00507 .
6
Chen CY, Cheng A, Tien FM, et al. Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies[J]. BMC Infect Dis, 2019, 19(1): 635. PMCID: PMC6637637. DOI: 10.1186/s12879-019-4260-4 .
7
Boussen I, Lisan Q, Raffoux E, et al. Hepatosplenic candidiasis in patients with hematological malignancies: a 13-year retrospective cohort study[J]. Open Forum Infect Dis, 2022, 9(4): ofac088. PMCID: PMC8962726. DOI: 10.1093/ofid/ofac088 .
8
徐兵, 郭绪涛, 魏永强, 等. 急性白血病并发慢性播散性念珠菌病的临床研究[J]. 中华内科杂志, 2008, 47(6): 468-471. DOI: 10.3321/j.issn:0578-1426.2008.06.010 .
9
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-2405. DOI: 10.1182/blood-2016-03-643544 .
10
Cui L, Li ZG, Chai YH, et al. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: the first nation-wide prospective multicenter study in China[J]. Am J Hematol, 2018, 93(7): 913-920. DOI: 10.1002/ajh.25124 .
11
Yang W, Cai J, Shen S, et al. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial[J]. Lancet Oncol, 2021, 22(9): 1322-1332. PMCID: PMC8416799. DOI: 10.1016/S1470-2045(21)00328-4 .
12
Zheng Y, Pan L, Li J, et al. Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia[J]. BMC Cancer, 2024, 24(1): 46. PMCID: PMC10775489. DOI: 10.1186/s12885-023-11784-4 .
13
中国医师协会血液科医师分会, 中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第六次修订版)[J]. 中华内科杂志, 2020, 59(10): 754-763. DOI: 10.3760/cma.j.cn112138-20200627-00624 .
14
曾其毅, 宋远斌, 陈志江, 等. 《2012拯救脓毒症运动: 严重脓毒症、脓毒症休克诊治指南》儿科部分解读[J]. 中华实用儿科临床杂志, 2013, 28(16): 1278-1280. DOI: 10.3760/cma.j.issn.2095-428X.2013.16.023 .
15
Madney Y, Shalaby L, Elanany M, et al. Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies[J]. Mycoses, 2020, 63(1): 30-37. DOI: 10.1111/myc.13002 .
16
Sahbudak Bal Z, Yilmaz Karapinar D, Karadas N, et al. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013[J]. Mycoses, 2015, 58(4): 225-232. DOI: 10.1111/myc.12303 .
17
Sun Y, Huang H, Chen J, et al. Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China[J]. Tumour Biol, 2015, 36(2): 757-767. DOI: 10.1007/s13277-014-2649-7 .
18
Ozsevik SN, Sensoy G, Karli A, et al. Invasive fungal infections in children with hematologic and malignant diseases[J]. J Pediatr Hematol Oncol, 2015, 37(2): e69-e72. DOI: 10.1097/MPH.0000000000000225 .
19
De Castro N, Mazoyer E, Porcher R, et al. Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007[J]. Clin Microbiol Infect, 2012, 18(6): E185-E187. DOI: 10.1111/j.1469-0691.2012.03819.x .
20
Sallah S, Wan JY, Nguyen NP, et al. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study[J]. Cancer, 2001, 92(6): 1349-1353. DOI: 10.1002/1097-0142(20010915)92:6<1349::aid-cncr1457>3.0.co;2-e .
21
Pestalozzi BC, Krestin GP, Schanz U, et al. Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia[J]. Blood, 1997, 90(10): 3858-3864.
22
Rammaert B, Desjardins A, Lortholary O. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis[J]. Mycoses, 2012, 55(3): e74-e84. DOI: 10.1111/j.1439-0507.2012.02182.x .
23
Semelka RC, Shoenut JP, Greenberg HM, et al. Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging[J]. J Magn Reson Imaging, 1992, 2(3): 341-345. DOI: 10.1002/jmri.1880020315 .
24
Anttila VJ, Elonen E, Nordling S, et al. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications[J]. Clin Infect Dis, 1997, 24(3): 375-380. DOI: 10.1093/clinids/24.3.375 .
25
Sallah S, Semelka R, Kelekis N, et al. Diagnosis and monitoring response to treatment of hepatosplenic candidiasis in patients with acute leukemia using magnetic resonance imaging[J]. Acta Haematol, 1998, 100(2): 77-81. DOI: 10.1159/000040869 .
26
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62(4): e1-50. PMCID: PMC4725385. DOI: 10.1093/cid/civ933 .
27
Groll AH, Castagnola E, Cesaro S, et al. Fourth European conference on infections in leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation[J]. Lancet Oncol, 2014, 15(8): e327-e340. DOI: 10.1016/S1470-2045(14)70017-8 .
28
L'Hotta AJ, Randolph SB, Reader B, et al. Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: a systematic review[J]. CA Cancer J Clin, 2023, 73(5): 524-545. PMCID: PMC10524286. DOI: 10.3322/caac.21783 .
29
Rossi F, Ricci F, Botti S, et al. The Italian consensus conference on the role of rehabilitation for children and adolescents with leukemia, central nervous system, and bone tumors, part 1: review of the conference and presentation of consensus statements on rehabilitative evaluation of motor aspects[J]. Pediatr Blood Cancer, 2020, 67(12): e28681. DOI: 10.1002/pbc.28681 .
30
Brown P, Inaba H, Annesley C, et al. Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020, 18(1): 81-112. DOI: 10.6004/jnccn.2020.0001 .

作者贡献声明

江信宏负责研究设计、文章撰写、论文修改;刘佩君负责病例资料收集、数据统计分析和部分经费支持;吴椿萍、翁开枝、庄树铨、黄淑贤、王晓芳负责病例资料收集和数据整理;郑湧智负责研究设计、数据统计分析、论文修改。

基金

福建医科大学启航基金项目资助(2023QH1042)

编委: 张辉

版权

版权所有 © 2023中国当代儿科杂志
PDF(920 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/